Cargando…

A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder

Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed to the average age of four years...

Descripción completa

Detalles Bibliográficos
Autores principales: Olesova, Dominika, Galba, Jaroslav, Piestansky, Juraj, Celusakova, Hana, Repiska, Gabriela, Babinska, Katarina, Ostatnikova, Daniela, Katina, Stanislav, Kovac, Andrej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693535/
https://www.ncbi.nlm.nih.gov/pubmed/33147863
http://dx.doi.org/10.3390/metabo10110443
_version_ 1783614766958247936
author Olesova, Dominika
Galba, Jaroslav
Piestansky, Juraj
Celusakova, Hana
Repiska, Gabriela
Babinska, Katarina
Ostatnikova, Daniela
Katina, Stanislav
Kovac, Andrej
author_facet Olesova, Dominika
Galba, Jaroslav
Piestansky, Juraj
Celusakova, Hana
Repiska, Gabriela
Babinska, Katarina
Ostatnikova, Daniela
Katina, Stanislav
Kovac, Andrej
author_sort Olesova, Dominika
collection PubMed
description Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed to the average age of four years or even more which adversely affects a child’s perspective. A laboratory method allowing to detect the disorder at earlier stages is of a great need, as this could help the patients to start with treatment at a younger age, even prior to the clinical diagnosis. Recent evidence indicates that metabolomic markers should be considered as diagnostic markers, also serving for further differentiation and characterization of different subgroups of the autism spectrum. In this study, we developed an ultra-high performance liquid chromatography-tandem triple quadrupole mass spectrometry method for the simultaneous determination of six metabolites in human urine. These metabolites, namely methylguanidine, N-acetyl arginine, inosine, indole-3-acetic acid, indoxyl sulfate and xanthurenic acid were selected as potential biomarkers according to prior metabolomic studies. The analysis was carried out by means of reversed-phase liquid chromatography with gradient elution. Separation of the metabolites was performed on a Phenomenex Luna(®) Omega Polar C18 (100 × 1.0 mm, 1.6 µm) column at a flow rate of 0.15 mL/min with acetonitrile/water 0.1% formic acid aqueous as the mobile phase. The analysis was performed on a group of children with autism spectrum disorder and age-matched controls. In school children, we have detected disturbances in the levels of oxidative stress markers connected to arginine and purine metabolism, namely methylguanidine and N-acetylargine. Also, products of gut bacteria metabolism, namely indoxyl sulfate and indole-3-acetic acid, were found to be elevated in the patients’ group. We can conclude that this newly developed method is fast, sensitive, reliable, and well suited for the quantification of proposed markers.
format Online
Article
Text
id pubmed-7693535
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76935352020-11-28 A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder Olesova, Dominika Galba, Jaroslav Piestansky, Juraj Celusakova, Hana Repiska, Gabriela Babinska, Katarina Ostatnikova, Daniela Katina, Stanislav Kovac, Andrej Metabolites Article Autism spectrum disorder is a heterogeneous neurodevelopmental disease. Currently, no biomarker of this disease is known. Diagnosis is performed through observation, standardized behavioral scales, and interviews with parents. In practice, diagnosis is often delayed to the average age of four years or even more which adversely affects a child’s perspective. A laboratory method allowing to detect the disorder at earlier stages is of a great need, as this could help the patients to start with treatment at a younger age, even prior to the clinical diagnosis. Recent evidence indicates that metabolomic markers should be considered as diagnostic markers, also serving for further differentiation and characterization of different subgroups of the autism spectrum. In this study, we developed an ultra-high performance liquid chromatography-tandem triple quadrupole mass spectrometry method for the simultaneous determination of six metabolites in human urine. These metabolites, namely methylguanidine, N-acetyl arginine, inosine, indole-3-acetic acid, indoxyl sulfate and xanthurenic acid were selected as potential biomarkers according to prior metabolomic studies. The analysis was carried out by means of reversed-phase liquid chromatography with gradient elution. Separation of the metabolites was performed on a Phenomenex Luna(®) Omega Polar C18 (100 × 1.0 mm, 1.6 µm) column at a flow rate of 0.15 mL/min with acetonitrile/water 0.1% formic acid aqueous as the mobile phase. The analysis was performed on a group of children with autism spectrum disorder and age-matched controls. In school children, we have detected disturbances in the levels of oxidative stress markers connected to arginine and purine metabolism, namely methylguanidine and N-acetylargine. Also, products of gut bacteria metabolism, namely indoxyl sulfate and indole-3-acetic acid, were found to be elevated in the patients’ group. We can conclude that this newly developed method is fast, sensitive, reliable, and well suited for the quantification of proposed markers. MDPI 2020-11-02 /pmc/articles/PMC7693535/ /pubmed/33147863 http://dx.doi.org/10.3390/metabo10110443 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Olesova, Dominika
Galba, Jaroslav
Piestansky, Juraj
Celusakova, Hana
Repiska, Gabriela
Babinska, Katarina
Ostatnikova, Daniela
Katina, Stanislav
Kovac, Andrej
A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder
title A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder
title_full A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder
title_fullStr A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder
title_full_unstemmed A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder
title_short A Novel UHPLC-MS Method Targeting Urinary Metabolomic Markers for Autism Spectrum Disorder
title_sort novel uhplc-ms method targeting urinary metabolomic markers for autism spectrum disorder
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693535/
https://www.ncbi.nlm.nih.gov/pubmed/33147863
http://dx.doi.org/10.3390/metabo10110443
work_keys_str_mv AT olesovadominika anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT galbajaroslav anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT piestanskyjuraj anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT celusakovahana anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT repiskagabriela anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT babinskakatarina anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT ostatnikovadaniela anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT katinastanislav anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT kovacandrej anoveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT olesovadominika noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT galbajaroslav noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT piestanskyjuraj noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT celusakovahana noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT repiskagabriela noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT babinskakatarina noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT ostatnikovadaniela noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT katinastanislav noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder
AT kovacandrej noveluhplcmsmethodtargetingurinarymetabolomicmarkersforautismspectrumdisorder